The pancreas has both endocrine and exocrine functions. As an endocrine organ, stimulation of the pancreatic ␤ -cells results in insulin secretion to control systemic glucose levels. The exocrine function of the pancreas and the need for alkaline pancreatic secretion have been appreciated for more than 40 years. Yet, our knowledge of the cellular mechanisms (signaling, transporters and channels) which accomplish these critical functions has evolved greatly.
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The major function of the exocrine pancreas is to produce and secrete digestive enzymes into the duodenum. To prevent the pancreas from digesting itself, these digestive enzymes are kept inactive by elevated pH ( 1 8.0) of the pancreatic juice. The high pH is the result of co-secretion of bicarbonate ). That said, the HCO 3 -concentration of secretions varies greatly between species: approximately 70-75 m M for rats and mice, and about 150 m M (isotonic NaHCO 3 ) for cats, guinea pigs and humans. It is this difference in the 2-fold HCO 3 -concentration which has perplexed physiologists for 30 years. Reaching 75 m M NaHCO 3 can be accomplished by the channels and transporters shown in figure 1 . However, additional HCO 3 -secretion must occur in the context of a continually decreasing ductal Cl -concentration, which, based on the transport shown in figure 1 , violates thermodynamics.
Pancreatic acinar cells are responsible for enzyme secretion while pancreatic ductal cells are responsible for ) uptake by NBCe1 (Slc4a4) was shown to be critical for the generation of approximately 75% of stimulated HCO 3 -secretion. In the last 10 years, several new HCO 3 - 3 -in the pancreatic duct is most obvious in cystic fibrosis [mutations in the cystic fibrosis transmembrane conductance regulator (CFTR)], whereas in the pancreas the mucus secretion blocks the ducts [1] .
In order to secrete HCO 3 -, ductal cells have HCO 3 -or H + transporters on both basolateral and apical membranes. Until recently, the major player in HCO 3 -secretion in the apical membrane was consider to be CFTR ( fig. 1 ) [2] [3] [4] . At that time, CFTR was consider to be a chloride channel capable of HCO 3 -transport activated by an increase in intracellular cAMP [5, 6] . The model indicated that activity of carbonic anhydrase produces HCO 3 -, which is then secreted into the ductal lumen. At the same time, an H + is transported into the cell by a Na -transport by CFTR is becoming more disputed in the pancreatic ductal cells [12] . This dispute was further complicated by the discoveries that Cl -:HCO 3 -coupling in mice is 2: 1 for Slc26a3 [13] and 1: 2 for Slc26a6 [13, 14] . A further feature is that human SLC26A6 coupling is 1: 1 [15] . Three of 11 members of the Slc26 family seem involved in pancreatic HCO 3 -secretion (Slc26a3, Slc26a6 and Slc26a9) [13, 16, 17] . All are found on apical epithelial membranes [17, 18] .
Slc26 proteins transport anions as exchangers or channels [18] [19] [20] [21] . Slc26a6 also transports oxalate, formate and sulfate [14, 22, 23] , whereas Slc26a9 possesses several transport modes: n Cl --HCO 3 -exchanger, anion channel [20, [24] [25] [26] and Na + transporter [26] . The relationship of Slc26 proteins with CFTR is a 2-way street. When R-CFTR binds the sulfate transporter anti-domain of Slc26a3 or Slc26a6, exchange activity is increased [13] while the same interaction with Slc26a9 inhibits transport [27] . This interaction also increases CFTR-Cl -channel activity [16, 21] , although Slc26a9-sulfate transporter anti-interaction activation requires cAMP [25, 28] . Not surprisingly, Slc26a9 does not stimulate ⌬ F508-CFTR activity [29] , the most common mutation in cystic fibrosis, implying that Slc26a9 may be associated with the severity of cystic fibrosis phenotypes.
Several of these interactions and regulatory cascades are controversial. Cl -exit via CFTR and H + recirculating by NHE3 [30] are necessary for Cl --HCO 3 -exchange activity of Slc26a3/Slc26a6 and HCO 3 -secretion. Slc26a6-like Cl --HCO 3 -exchange activity increases with CFTR inhibition in the apical membrane of guinea pig pancreatic ductal cells [31] , opposed to the results in HEK-293 cells [13] . Similarly, Slc26a9 [24] as well as CFTR [32] can be inhibited by WNK1/4 [with no lysine (K) 1/4] kinases, which are mutated in familial hyperkalemic hypertension. At physiological inositol-3-phosphate, its receptor releases IRBIT (inositol 1,4,5-trisphosphate receptorbinding protein) to apparently activate downstream molecules. Recently, IRBIT was found to increase basolateral NBCe1 [33, 34] and CFTR activity [34] ( fig. 2 ) . Thus, increasing IRBIT in pancreatic ductal cells would lead to stimulation of transductal HCO 3 -secretion [34] . Future studies will almost certainly reveal additional details of the regulation as well as the pathophysiology of pancreatic HCO 3 -secretion. Fortunately, we can now at least account for the mechanism of isotonic NaHCO 3 secretion found in humans. Clinic Center for Cell Signaling in Gastroenterology (P30-DK084567). 
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